Researchers described that hepatocyte dedifferentiation was associated with disease severity and a reduced synthetic capacity of the liver. Moreover, they identify the CXCR4 pathway as a driver of hepatocyte dedifferentiation and as a therapeutic target in alcohol-related hepatitis.
[Journal Of Hepatology]